Literature DB >> 30442498

Interleukin 2 plus anti-GD2 immunotherapy: helpful or harmful?

Katherine K Matthay1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30442498     DOI： 10.1016/S1470-2045(18)30627-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy.

Authors:  Liyu Zhang; Meng Wang; Zeen Zhu; Chenxi Ding; Shengquan Chen; Haibin Wu; Ying Yang; Fengyu Che; Qiao Li; Hui Li
Journal:  Int J Nanomedicine       Date:  2021-05-10

2.  HMGB3 is Associated With an Unfavorable Prognosis of Neuroblastoma and Promotes Tumor Progression by Mediating TPX2.

Authors:  Xiaodan Zhong; Songling Zhang; Yutong Zhang; Zongmiao Jiang; Yanan Li; Jian Chang; Junqi Niu; Ying Shi
Journal:  Front Cell Dev Biol       Date:  2021-12-20

3.  Mesenchymal stem cells promote caspase-3 expression of SH-SY5Y neuroblastoma cells via reducing telomerase activity and telomere length.

Authors:  Ezzatollah Fathi; Somayeh Vandghanooni; Soheila Montazersaheb; Raheleh Farahzadi
Journal:  Iran J Basic Med Sci       Date:  2021-11       Impact factor: 2.699

Review 4.  Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma.

Authors:  Hui Yan; Bo Zhai; Fang Yang; Zhenliang Chen; Qiang Zhou; Ana Cláudia Paiva-Santos; Ziqiao Yuan; Yang Zhou
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

5.  Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies.

Authors:  Irina V Kholodenko; Daniel V Kalinovsky; Elena V Svirshchevskaya; Igor I Doronin; Maria V Konovalova; Alexey V Kibardin; Tatyana V Shamanskaya; Sergey S Larin; Sergey M Deyev; Roman V Kholodenko
Journal:  Molecules       Date:  2019-10-24       Impact factor: 4.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.